Temozolomide Plus Radiotherapy Improves Survival in Non-Co-Deleted Glioma
Combination treatment of temozolomide plus radiotherapy improves survival in non-co-deleted gliomas.
The presence of visible fluorescence can serve as an intraoperative diagnostic surgical biomarker of high-grade glioma within a brain tumor.
For patients with melanoma and untreated brain metastases, nivolumab combined with ipilimumab shows clinically meaningful efficacy.
PVSRIPO is a prototypic oncolytic recombinant polio virus vaccine that recognizes the poliovirus receptor CD155, which is widely expressed in neoplastic cells of solid tumors.